Wolfgang Plischke is a German businessperson who has been at the helm of 8 different companies. Presently, Dr. Plischke is Chairman-Supervisory Board at Evotec SE, Chairman-Supervisory Board for Bayer Technology Services GmbH, Chairman-Supervisory Board for Bayer Real Estate GmbH and Chairman-Supervisory Board for Bayer Innovation GmbH.

He is also on the board of Bayer AG, Paul Ehrlich-Foundation, German Chemical Industry Fund and Walter Siegenthaler Gesellschaft and Chairman-Executive Board at Robert Koch Stiftung eV, Vice President of European Chemical Industry Council, Member-Executive Board at German Asia Pacific Business Association, Member of Helmholtz-Gemeinschaft Deutscher Forschungszentren eV, Member-Executive Board at Bundesverband der Deutschen Industrie e.V. and Council Member at the University of Hohenheim.

Dr. Plischke previously was Chairman of Verband Forschender Arzneimittelhersteller e.V., Chairman-Supervisory Board of Covestro AG, President of Bayer Yakuhin Ltd., Head-Pharmaceuticals Division at Bayer HealthCare AG and Head-International Strategic Marketing at Bayer Pharma AG.

Wolfgang Plischke received an undergraduate degree and a doctorate from the University of Hohenheim.